Skip to main content
SpringerLink
Log in

Lantana camara enhances antibacterial potency of antibiotics and exerts synergistic inhibitory effect against pathogenic bacterial species

  • Research Article
  • Published:
Oriental Pharmacy and Experimental Medicine Aims and scope Submit manuscript

Abstract

The present study aims at evaluating the potentiating ability of Lantana camara leaves and flower extracts in enhancing the antibacterial efficacy of antibiotics against pathogenic bacterial species. Methanolic extracts of L. camara leaves and flowers (pink turn yellow) were prepared by the solvent extraction method. The leaves and flower extracts alone and their combination with five different antibiotics; Ciprofloxacin, Streptomycin, Tetracycline, Nalidixic acid and Norfloxacin were assessed for their synergistic antibacterial potential against Escherichia coli MTCC 1698, Staphylococcus aureus MTCC 3160, Enterobacter fecalis MTCC 439, Proteus vulgaris MTCC 1771 and Salmonella typhi MTCC 733, using an agar disc diffusion method and checkerboard antibacterial susceptibility assay. The minimum inhibitory concentration of Lantana extracts and antibiotics was assessed using broth micro-dilution assay. In agar disc diffusion assay, the combination of the flower extract and streptomycin depicted 5.26–25% increase in ZOI against S. aureus, and S. typhi. In the checkerboard antibacterial assay, the Ciprofloxacin and flower extract showed a synergistic inhibitory effect against E. coli, S. aureus, E. fecalis, P. vulgaris and S. typhi (FIC index, ranging from 0.39 to 0.14), while the combination of leaves extract and streptomycin exerted additive effect against S. typhi and E. coli (FICI = 0.46 and 0.48 respectively). The MICs of Lantana leaves and flower extracts against the test bacterial strains were depicted between 31.25 μg/ml and 250 µg/ml. L. camara leaves and flower extracts enhance the antibacterial potency of antibiotics and their synergistic combination could emerge as a novel therapeutics against pathogenic bacterial species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

LL:

Lantana leaves

LF:

Lantana flower

MDR:

Multiple drug resistance

CPL:

Ciprofloxacin

STR:

Streptomycin

TET:

Tetracycline

NLX:

Nalidixic acid

NOR:

Norfloxacin

MHB:

Muller Hinton broth

MHA:

Muller Hinton agar

ZOI:

Zone of inhibition

FIC:

Fractional inhibitory concentration

FICI:

Fractional inhibitory concentration index

MIC:

Minimum inhibitory concentration

SD:

Standard deviation

S:

Synergism

I:

Indifference

A:

Antagonism

D:

Additive

References

  • Aiyegoro OA, Okoh AI (2009) Use of bioactive plant products in combination with standard antibiotics: implications in antimicrobial chemotherapy. J Med Plant Res 3:1147–1152

    CAS  Google Scholar 

  • Aly MM, Al-Ghamdi M, Bafeel SO, Khedr AM (2013) Antimicrobial and phytochemical analysis of essential oils of Lavandula dentate and Plectranthus nudiflorus, collected from Al baha region. Saudi Arabia Life Sci J 10:3302–3309

    Google Scholar 

  • Anand J, Chaudhary S, Rai N (2018) Analysis of antioxidant, total phenolic content and total flavonoid content of Lantana camara leaves and flowers. Asian J Pharma Clin Res 11(4):203–206

    Article  Google Scholar 

  • Anand J, Upadhayaya B, Rawat P, Rai N (2015) Biochemical characterization and pharmacognostic evaluation of purified catechins in green tea (Camellia sinensis) cultivars of India. Biotech 5:285–294

    Google Scholar 

  • Barreto FS, Sousa EO, Campos AR, Costa JGM, Rodrigues FFG (2010) Antibacterial activity of Lantana camara Linn and Lantana montevidensis brig extracts from Cariri-Ceara, Brazil. J Young Pharm 2:42–44

    Article  Google Scholar 

  • Bassetti M, Ginocchio F, Mikulska M (2011) New treatment options against gram-negative organisms. Crit Care 15:215

    Article  Google Scholar 

  • Caesar P, Kumar J (2016) In-vitro antibacterial activity in different extracts of Lantana camara L. leaf fraction. J Pharma Res 10:301–303

    Google Scholar 

  • CLSI (2008) Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, CLSI document M100-S18, 7th edn. Clinical and Laboratory Standards Institute, Wayne

    Google Scholar 

  • Eldeen IMS, Elgorashi EE, Van SJ (2005) Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. J Ethnopharma 102:457–464

    Article  CAS  Google Scholar 

  • Girish K (2017) Antimicrobial activities of Lantana camara Linn. Asian J Pharma Clin Res 10:57–67

    Article  CAS  Google Scholar 

  • Hemaiswarya S, Kruthiventi AK, Doble MC (2008) Synergism between natural products and antibiotics against infectious diseases. Phytomed 15:639–652

    Article  CAS  Google Scholar 

  • Hoagland DT, Liu J, Lee RB, Lee RE (2016) New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Del Rev 102:55–72

    Article  CAS  Google Scholar 

  • Inbaraj SD, Godfred M, Glory JI, Muniappan M, Muthiah NS (2014) Antibacterial effect of Lantana camara Linn. on gram negative bacteria and Ndm-1. Strain: an in vitro study. Asian J Pharm Clin Res 7:9–12

    Google Scholar 

  • Inbathamizh L, Padmini E (2013) Effect of geographical properties on the phytochemical composition and antioxidant potential of Moringa oleifera flowers. BioMedRx 1:239–247

    Google Scholar 

  • Jorgensen JH, Turnidge JP (2007) Susceptibility test methods: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, 9th edn. ASM Press, Washington, DC, pp 1152–1172

    Google Scholar 

  • Miller WR, Munita JM, Arias CA (2014) Mechanisms of antibiotic resistance in enterococci. Expert Rev Ant Infect Ther 12:1221–1236

    Article  CAS  Google Scholar 

  • Mohan JC, Subalakshmi T (2017) Screening of antibacterial activity of Lantana camara against selected poultry pathogens. World J Phar Pharma Sci 6:1146–1152

    CAS  Google Scholar 

  • Mostafa AA, Al-Askar AA, Almaary KS Dawoud TM Sholkamy EN, Bakri MM (2017) Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J Biol Sci 25(2):361–366

    Article  Google Scholar 

  • Naz R, Bano A (2013) Phytochemical screening, antioxidants and antimicrobial potential of Lantana camara in different solvents. Asian Pac J Trop Dis 3:480–486

    Article  CAS  Google Scholar 

  • Noor S (2016) Synergistic effect of the methanolic extract of lemongrass and some antibiotics to treat urinary tract bacteria. J Biosci Med 4:48–58

    CAS  Google Scholar 

  • Razmavar S, Abdulla MA, Ismail SB, Hassandarvish P (2014) Antibacterial activity of leaf extracts of Baeckea frutescens against Methicillin-Resistant Staphylococcus aureus. Biomed Res Int 521287:5

    Google Scholar 

  • Salada JT, Balala LM, Vasquez EA (2015) Phytochemical and antibacterial studies of Lantana camara L. leaf fraction and essential oil. Int J Sci Res Pub 5:1–5

    Google Scholar 

  • Sampaio BL, Edrada-Ebel R, Da Costa FB (2016) Effect of the environment on the secondary metabolic profile of Tithonia diversifolia: a model forenvironmental metabolomics of plants. Sci Rep 6:1–11

    Article  Google Scholar 

  • Sousa EO, Costa JGM (2012) Genus Lantana: chemical aspects and biological activities. Braz J Pharmacogn 22:155–1180

    Google Scholar 

  • Swamy MK, Sinniah UR, Akhtar MS (2015) In vitro pharmacological activities and GC-MS analysis of different solvent extracts of Lantana camara leaves collected from tropical region of Malaysia. Evid Based Comput Alter Med 2015:1–9

    Article  Google Scholar 

  • Tamma PD, Cosgrove SE, Maragakis LL (2012) Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25:450–470

    Article  CAS  Google Scholar 

  • Turnidge JD, Ferraro MJ, Jorgensen JH (2007) Susceptibility test methods. General considerations. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, 9th edn. ASM Press, Washington, DC, pp 1146–1151

    Google Scholar 

  • Worthington RJ, Melander C (2013) Combination approaches to combat multi-drug resistant bacteria. Trend Biotechnol 31:177–184

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the Department of Biotechnology, Graphic Era University, Dehradun and Department of Microbiology, Uttaranchal College of Science and Technology, Dehradun for providing necessary technical facilities in conducting the research work.

Author information

Authors and Affiliations

  1. Department of Biotechnology, Graphic Era (Deemed to be University), 566/6, Bell Road, Clement Town, Dehradun, Uttarakhand, 248002, India

    Jigisha Anand & Nishant Rai

  2. Department of Microbiology, Uttaranchal College of Science and Technology, Dehradun, Uttarakhand, 248001, India

    Shanu Choudhary

Authors
  1. Jigisha Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shanu Choudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nishant Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jigisha Anand.

Ethics declarations

Ethical statement

Not applicable.

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anand, J., Choudhary, S. & Rai, N. Lantana camara enhances antibacterial potency of antibiotics and exerts synergistic inhibitory effect against pathogenic bacterial species. Orient Pharm Exp Med 18, 381–389 (2018). https://doi.org/10.1007/s13596-018-0321-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13596-018-0321-2

Keywords

Search

Navigation